Equities analysts expect CryoPort, Inc. (NASDAQ:CYRX) to post earnings of ($0.09) per share for the current quarter, according to Zacks. Two analysts have made estimates for CryoPort’s earnings. The lowest EPS estimate is ($0.09) and the highest is ($0.08). CryoPort reported earnings of ($0.19) per share during the same quarter last year, which would indicate a positive year over year growth rate of 52.6%. The firm is expected to report its next earnings report after the market closes on Tuesday, August 8th.

According to Zacks, analysts expect that CryoPort will report full-year earnings of ($0.34) per share for the current financial year, with EPS estimates ranging from ($0.36) to ($0.32). For the next year, analysts expect that the firm will post earnings of ($0.26) per share, with EPS estimates ranging from ($0.27) to ($0.26). Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that cover CryoPort.

CryoPort (NASDAQ:CYRX) last posted its quarterly earnings data on Thursday, May 4th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.14) by $0.04. The company had revenue of $2.71 million during the quarter, compared to analyst estimates of $2.59 million. CryoPort had a negative return on equity of 104.79% and a negative net margin of 137.99%.

CYRX has been the subject of several analyst reports. Needham & Company LLC restated a “buy” rating and issued a $6.00 price objective on shares of CryoPort in a research note on Thursday, July 13th. ValuEngine upgraded CryoPort from a “sell” rating to a “hold” rating in a research note on Thursday, May 11th. Janney Montgomery Scott initiated coverage on CryoPort in a research note on Wednesday, July 12th. They issued a “buy” rating and a $8.00 price objective for the company. Finally, Cowen and Company initiated coverage on CryoPort in a research note on Friday, June 16th. They issued an “outperform” rating and a $5.50 price objective for the company.

Shares of CryoPort (NASDAQ CYRX) opened at 7.04 on Thursday. CryoPort has a 1-year low of $1.80 and a 1-year high of $7.18. The company’s 50-day moving average price is $5.30 and its 200 day moving average price is $3.65. The company’s market cap is $168.78 million.

A hedge fund recently bought a new stake in CryoPort stock. Taylor Wealth Management Partners purchased a new position in CryoPort, Inc. (NASDAQ:CYRX) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 376,240 shares of the company’s stock, valued at approximately $1,851,000. Taylor Wealth Management Partners owned about 1.57% of CryoPort at the end of the most recent quarter. 10.67% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Zacks: Analysts Anticipate CryoPort, Inc. (NASDAQ:CYRX) Will Announce Earnings of -$0.09 Per Share” was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.dailypolitical.com/2017/08/06/zacks-analysts-anticipate-cryoport-inc-nasdaqcyrx-will-announce-earnings-of-0-09-per-share.html.

About CryoPort

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Get a free copy of the Zacks research report on CryoPort (CYRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with MarketBeat.com's FREE daily email newsletter.